.@ChuckGrassley and @SenKevinCramer's op-ed: Prescription drug middlemen, as well as drug manufacturers, too often respond to the current incentives in the system by putting their financial gain ahead of patients.https://www.washingtonexaminer.com/opinion/op-eds/sens-grassley-and-cramer-how-congress-can-fix-high-drug-prices …
.@ChuckGrassley and @SenKevinCramer's op-ed in @dcexaminer: A pointed example is the egregious increase in the cost of insulin. Though this drug has been available for nearly a century, its list price has recently skyrocketed.